Kiniksa Pharmaceuticals Ltd (KNSA) — Free Cash Flow Generation Index
Kiniksa Pharmaceuticals Ltd (KNSA) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $50.04 Million represents 1% of operating cash flow ($50.20 Million). Read KNSA liabilities breakdown for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Kiniksa Pharmaceuticals Ltd Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for Kiniksa Pharmaceuticals Ltd across 4 annual periods. Explore KNSA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Kiniksa Pharmaceuticals Ltd (2022–2025)
Year-by-year Free Cash Flow Generation Index for Kiniksa Pharmaceuticals Ltd. For the full company profile including market capitalisation, see KNSA company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | $25.41 Million | $25.69 Million | $277.00K | ▲ +0.0% |
| 2024 | 0.99x | $25.41 Million | $25.69 Million | $277.00K | ▼ -0.1% |
| 2023 | 0.99x | $13.17 Million | $13.30 Million | $130.00K | ▲ +0.8% |
| 2022 | 0.98x | $5.70 Million | $5.81 Million | $105.00K | — |